BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16278819)

  • 1. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.
    Bravou V; Klironomos G; Papadaki E; Taraviras S; Varakis J
    J Pathol; 2006 Jan; 208(1):91-9. PubMed ID: 16278819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-linked kinase cytoplasmic and nuclear expression in laryngeal carcinomas.
    Goulioumis AK; Bravou V; Varakis J; Goumas P; Papadaki H
    Virchows Arch; 2008 Nov; 453(5):511-9. PubMed ID: 18813944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
    Naves MA; Requião-Moura LR; Soares MF; Silva-Júnior JA; Mastroianni-Kirsztajn G; Teixeira VP
    J Nephrol; 2012; 25(3):401-9. PubMed ID: 21928230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILK overexpression in human hepatocellular carcinoma and liver cirrhosis correlates with activation of Akt.
    Peroukides S; Bravou V; Varakis J; Alexopoulos A; Kalofonos H; Papadaki H
    Oncol Rep; 2008 Dec; 20(6):1337-44. PubMed ID: 19020711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion.
    Papanikolaou S; Bravou V; Gyftopoulos K; Nakas D; Repanti M; Papadaki H
    Histopathology; 2010 May; 56(6):799-809. PubMed ID: 20546345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis.
    Zhao D; Tang XF; Yang K; Liu JY; Ma XR
    Clin Exp Metastasis; 2012 Dec; 29(8):957-69. PubMed ID: 22638656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the integrin-linked kinase pathway in hexachlorobenzene-induced gender-specific rat hepatocarcinogenesis.
    Plante I; Cyr DG; Charbonneau M
    Toxicol Sci; 2005 Dec; 88(2):346-57. PubMed ID: 16162845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.
    De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F
    APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.
    Marotta A; Parhar K; Owen D; Dedhar S; Salh B
    Br J Cancer; 2003 Jun; 88(11):1755-62. PubMed ID: 12771992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway.
    Piao Z; Hong CS; Jung MR; Choi C; Park YK
    Biochem Biophys Res Commun; 2014 Sep; 452(3):858-64. PubMed ID: 25218472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
    Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
    Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
    Joshi MB; Ivanov D; Philippova M; Erne P; Resink TJ
    FASEB J; 2007 Oct; 21(12):3083-95. PubMed ID: 17485554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT).
    Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Zwawa K; McCubrey JA; Laidler P
    Adv Enzyme Regul; 2011; 51(1):195-207. PubMed ID: 21035499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.
    Huang HC; Hu CH; Tang MC; Wang WS; Chen PM; Su Y
    Oncogene; 2007 Apr; 26(19):2781-90. PubMed ID: 17072345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
    Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
    Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and β-catenin and enhances invasion in nasopharyngeal carcinoma cells.
    Yip WK; Seow HF
    Cancer Lett; 2012 May; 318(2):162-72. PubMed ID: 22182447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
    Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
    Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.